Improved
6112 HealthChanged
3786 LivesSaved
3568 Lives0 lives impacted in the last 24 hrs Learn More
Dr. Handelsman describes metabolic syndrome, which places patients at an increased risk for coronary artery disease and type 2 diabetes says the American Heart Association.
About Dr. Yehuda Handelsman, M.D.:
Dr. Yehuda Handelsman is an endocrinologist in solo practice in Tarzana, California; Medical Director, Metabolic Institute of America; and Senior Scientific Consultant, Metabolic Endocrine Education Foundation. He is a summa cum laude graduate of the University of the Pacific, Stockton, California, and a fellow of the American College of Endocrinology and the American College of Physicians. Dr. Handelsman obtained his MD from Tel Aviv University, Israel; residency in internal medicine at New York Infirmary Beekman Downtown Hospital - New York University, New York; and fellowship in diabetes and endocrinology, University of Southern California Medical School, Los Angeles. Currently, he is Secretary of AACE and a member of the Executive Committee.
Visit Dr. Handelsman at the Metabolic Institute of America